{"title":"Topiramate compares favorably to naltrexone for alcohol use disorder","authors":"","doi":"10.1002/pu.31213","DOIUrl":null,"url":null,"abstract":"<p>A 12-week randomized trial involving 147 participants has found that topiramate was as effective as naltrexone in reducing drinking behaviors in patients with alcohol use disorder (AUD). A secondary analysis found no association between two gene polymorphisms and patient response to the medication treatments.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 10","pages":"3"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31213","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
A 12-week randomized trial involving 147 participants has found that topiramate was as effective as naltrexone in reducing drinking behaviors in patients with alcohol use disorder (AUD). A secondary analysis found no association between two gene polymorphisms and patient response to the medication treatments.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
